ℹ️
🇬🇧
Search
Search for people relevant for "Minimal Residual Disease"
Minimal Residual Disease
Person
Class
Person
Publication
Programmes
Export current view
MUDr. Markéta Kubričanová Žaliová Ph.D.
Academic staff at Second Faculty of Medicine
81 publications
Publications
publication
IKZF1(plus) Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia
2018 |
Second Faculty of Medicine
publication
Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology
2017 |
Second Faculty of Medicine
publication
Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study
2016 |
Second Faculty of Medicine
publication
Implications of delayed bone marrow aspirations at the end of treatment induction for risk stratification and outcome in children with acute lymphoblastic leukaemia
2016 |
Second Faculty of Medicine
publication
Aetiology of childhood ALL and AML, molecular genetics and minimal residual disease
2015 |
Second Faculty of Medicine
publication
CD2-positive B-cell precursor acute lymphoblastic leukemia with an early switch to the monocytic lineage
2014 |
First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport, Central Library of Charles University
publication
Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemia
2014 |
Second Faculty of Medicine
publication
Acute Leukemias with ETV6/ABL1 (TEL/ABL) Fusion: Poor Prognosis and Prenatal Origin
2010 |
First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
publication
Quantification of fusion transcript reveals a subgroup with distinct biological properties and predicts relapse in BCR/ABL-positive ALL: implications for residual disease monitoring
2009 |
Second Faculty of Medicine
publication
Laboratory testing for the presence of minimal residual disease using DNA-based RQ-PCR for clonal rearrangements of Ig/TCR defined by PCR or massive parallel sequencing (NGS)
Publication without faculty affiliation
Load more publications (71)
Loading network view...